Mirae Asset Global Investments’s 10x Genomics TXG Stock Holding History

Mirae Asset Global Investments’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Sell	5,227 -911	-15%	-$23.9K	﹤0.01%	1117
2026 Q1	$130K	Buy	6,138 +478	+8%	+$9.56K	﹤0.01%	1139
2025 Q4	$92.3K	Buy	5,660 +1,237	+28%	+$18.7K	﹤0.01%	1277
2025 Q3	$51.7K	Buy	4,423 +132	+3%	+$1.72K	﹤0.01%	1334
2025 Q2	$49.7K	Buy	4,291 +669	+18%	+$6.1K	﹤0.01%	1258
2025 Q1	$33.2K	Buy	3,622 +56	+2%	+$706	﹤0.01%	1316
2024 Q4	$52K	Buy	+3,566	New	+$56.3K	﹤0.01%	1262
2024 Q2	–	Sell	-319,287	Closed	-$15.6M	–	2480
2024 Q1	$15.6M	Buy	319,287 +231,697	+265%	+$10.2M	0.03%	463
2023 Q4	$4.9M	Sell	87,590 -79,904	-48%	-$3.48M	0.01%	901
2023 Q3	$6.91M	Buy	167,494 +15,256	+10%	+$794K	0.02%	759
2023 Q2	$8.5M	Sell	152,238 -169,839	-53%	-$9.19M	0.02%	718
2023 Q1	$18M	Buy	322,077 +4,265	+1%	+$199K	0.04%	428
2022 Q4	$11.6M	Buy	+317,812	New	+$10.4M	0.03%	548

Other funds holding TXG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Mirae Asset Global Investments's TXG Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its 10x Genomics (TXG) stake by 15% in Q2 2026, selling an estimated $23.9K and leaving 5,227 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Mirae Asset Global Investments first reported a position in TXG in Q4 2022 and has held it in 13 quarters since. The position peaked at $18M in Q1 2023. 157 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Mirae Asset Global Investments held 5,227 shares of 10x Genomics worth $200K as of Q2 2026.
Mirae Asset Global Investments sold 911 10x Genomics shares in Q2 2026, an estimated $23.9K.
10x Genomics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1117 holding.
Mirae Asset Global Investments first reported a position in 10x Genomics in Q4 2022 and has held it in 13 quarters since.
Mirae Asset Global Investments's 10x Genomics position peaked at $18M in Q1 2023.
157 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.